| Steven V Turpin, MD | |
|
515 Wekiva Commons Cir, Apopka, FL 32712-3645 | |
| (407) 464-9516 | |
| (407) 464-9519 |
| Full Name | Steven V Turpin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 40 Years |
| Location | 515 Wekiva Commons Cir, Apopka, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427090109 | NPI | - | NPPES |
| 370854300 | Medicaid | FL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventhealth Orlando | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Florida Hospitalist Partners Pa | 5799689931 | 81 |
| Hmv Diagnostics Inc | 8123172020 | 38 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Central Florida Hospitalist Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558381921 PECOS PAC ID: 5799689931 Enrollment ID: O20031120000518 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Cogent Healthcare Of Pensacola Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346287182 PECOS PAC ID: 1153226766 Enrollment ID: O20031205000170 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Central Florida Inpatient Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228859 PECOS PAC ID: 7911805254 Enrollment ID: O20031223000824 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Hmv Diagnostics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043460744 PECOS PAC ID: 8123172020 Enrollment ID: O20100408000469 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Ridgewood Physician Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295216034 PECOS PAC ID: 0446594105 Enrollment ID: O20181206001200 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Entity Name | Value Based Inpatient Specialist |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790260388 PECOS PAC ID: 9436589553 Enrollment ID: O20200413003448 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven V Turpin, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 | Steven V Turpin, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Millions of Americans with chronic conditions could save money on the drugs and medical services they need the most, if their health insurance plans decide to take advantage of a new federal rule issued today.
Every year in the United States, thousands of high-risk fracture patients who have been admitted to trauma centers will suffer life-threatening blood clots related to the fracture. In rare cases these clots can even travel to the lungs, where they can cause sudden death.
Representatives of the German Centre for Neurodegenerative Diseases, the UK Medical Research Council and the Canadian Institutes of Health Research today signed a cooperation agreement that aims to establish and apply harmonised guidelines and technologies for research on neurodegenerative diseases.
InDevR, a Boulder-based biotechnology company that develops advanced life science instrumentation and assays for analysis of viruses and other microorganisms, announced today the launch revolutionary new technology for microbiological analysis.
› Verified 2 days ago
Yorlenis Rodriguez, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 N Park Ave, Apopka, FL 32703 Phone: 407-889-1953 | |
Ramiro Zurita, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Dr. Louis Padgett, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9519 Fax: 407-464-9519 | |
Dr. Bolanle Akakabota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 | |
Zaid Tabbaa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Leah Delumpa, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Dr. Soheil Peiman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 |